nodes	percent_of_prediction	percent_of_DWPC	metapath
Papaverine—Tofisopam—PDE2A—breast cancer	0.0133	0.55	CrCbGaD
Papaverine—PDE10A—adipose tissue—breast cancer	0.00902	0.0673	CbGeAlD
Papaverine—PDE3B—pituitary gland—breast cancer	0.00844	0.063	CbGeAlD
Papaverine—PDE3B—adipose tissue—breast cancer	0.0084	0.0627	CbGeAlD
Papaverine—PDE10A—adrenal gland—breast cancer	0.00809	0.0604	CbGeAlD
Papaverine—PDE10A—female gonad—breast cancer	0.00754	0.0563	CbGeAlD
Papaverine—PDE3B—adrenal gland—breast cancer	0.00754	0.0563	CbGeAlD
Papaverine—PDE3B—bone marrow—breast cancer	0.00729	0.0544	CbGeAlD
Papaverine—PDE4B—nipple—breast cancer	0.0068	0.0508	CbGeAlD
Papaverine—PDE3B—endocrine gland—breast cancer	0.00654	0.0488	CbGeAlD
Papaverine—PDE3A—adipose tissue—breast cancer	0.00513	0.0383	CbGeAlD
Papaverine—PDE10A—lymph node—breast cancer	0.00485	0.0362	CbGeAlD
Papaverine—PDE3A—female reproductive system—breast cancer	0.00472	0.0352	CbGeAlD
Papaverine—PDE3A—adrenal gland—breast cancer	0.0046	0.0344	CbGeAlD
Papaverine—PDE3B—lymph node—breast cancer	0.00452	0.0337	CbGeAlD
Papaverine—PDE3A—female gonad—breast cancer	0.00429	0.0321	CbGeAlD
Papaverine—PDE4B—endometrium—breast cancer	0.00411	0.0307	CbGeAlD
Papaverine—PDE3A—endocrine gland—breast cancer	0.00399	0.0298	CbGeAlD
Papaverine—PDE4B—pituitary gland—breast cancer	0.00372	0.0277	CbGeAlD
Papaverine—PDE4B—adipose tissue—breast cancer	0.0037	0.0276	CbGeAlD
Papaverine—PDE4B—female reproductive system—breast cancer	0.0034	0.0254	CbGeAlD
Papaverine—PDE4B—adrenal gland—breast cancer	0.00332	0.0248	CbGeAlD
Papaverine—PDE4B—bone marrow—breast cancer	0.00321	0.024	CbGeAlD
Papaverine—PDE4B—female gonad—breast cancer	0.0031	0.0231	CbGeAlD
Papaverine—Trimethoprim—TYMS—breast cancer	0.00304	0.126	CrCbGaD
Papaverine—PDE4B—endocrine gland—breast cancer	0.00288	0.0215	CbGeAlD
Papaverine—PDE3A—lymph node—breast cancer	0.00276	0.0206	CbGeAlD
Papaverine—PDE4B—lymph node—breast cancer	0.00199	0.0149	CbGeAlD
Papaverine—Rash—Lapatinib—breast cancer	0.00188	0.00522	CcSEcCtD
Papaverine—Dermatitis—Lapatinib—breast cancer	0.00188	0.00521	CcSEcCtD
Papaverine—Diarrhoea—Fulvestrant—breast cancer	0.00187	0.00521	CcSEcCtD
Papaverine—Headache—Lapatinib—breast cancer	0.00187	0.00519	CcSEcCtD
Papaverine—Flushing—Melphalan—breast cancer	0.00185	0.00514	CcSEcCtD
Papaverine—Decreased appetite—Anastrozole—breast cancer	0.00184	0.00511	CcSEcCtD
Papaverine—Decreased appetite—Letrozole—breast cancer	0.00184	0.00511	CcSEcCtD
Papaverine—Constipation—Letrozole—breast cancer	0.00181	0.00502	CcSEcCtD
Papaverine—Constipation—Anastrozole—breast cancer	0.00181	0.00502	CcSEcCtD
Papaverine—Nausea—Lapatinib—breast cancer	0.00177	0.00492	CcSEcCtD
Papaverine—Verapamil—SLCO1B1—breast cancer	0.00176	0.073	CrCbGaD
Papaverine—Decreased appetite—Idarubicin—breast cancer	0.00174	0.00485	CcSEcCtD
Papaverine—Feeling abnormal—Anastrozole—breast cancer	0.00174	0.00484	CcSEcCtD
Papaverine—Feeling abnormal—Letrozole—breast cancer	0.00174	0.00484	CcSEcCtD
Papaverine—Rash—Fulvestrant—breast cancer	0.00173	0.0048	CcSEcCtD
Papaverine—Dermatitis—Fulvestrant—breast cancer	0.00172	0.0048	CcSEcCtD
Papaverine—Headache—Fulvestrant—breast cancer	0.00172	0.00477	CcSEcCtD
Papaverine—Rash—Toremifene—breast cancer	0.0017	0.00474	CcSEcCtD
Papaverine—Dermatitis—Toremifene—breast cancer	0.0017	0.00473	CcSEcCtD
Papaverine—Headache—Toremifene—breast cancer	0.00169	0.00471	CcSEcCtD
Papaverine—Ill-defined disorder—Vinblastine—breast cancer	0.00169	0.00471	CcSEcCtD
Papaverine—Malaise—Vinblastine—breast cancer	0.00164	0.00457	CcSEcCtD
Papaverine—Vertigo—Vinblastine—breast cancer	0.00164	0.00456	CcSEcCtD
Papaverine—Diarrhoea—Exemestane—breast cancer	0.00163	0.00452	CcSEcCtD
Papaverine—Nausea—Fulvestrant—breast cancer	0.00163	0.00452	CcSEcCtD
Papaverine—Flushing—Vinorelbine—breast cancer	0.00162	0.00449	CcSEcCtD
Papaverine—Nausea—Toremifene—breast cancer	0.00161	0.00446	CcSEcCtD
Papaverine—Ill-defined disorder—Goserelin—breast cancer	0.00157	0.00437	CcSEcCtD
Papaverine—Anorexia—Chlorambucil—breast cancer	0.00155	0.00431	CcSEcCtD
Papaverine—Diarrhoea—Ixabepilone—breast cancer	0.00154	0.00427	CcSEcCtD
Papaverine—Discomfort—Vinblastine—breast cancer	0.00153	0.00427	CcSEcCtD
Papaverine—Malaise—Goserelin—breast cancer	0.00153	0.00424	CcSEcCtD
Papaverine—Rash—Exemestane—breast cancer	0.0015	0.00417	CcSEcCtD
Papaverine—Dermatitis—Exemestane—breast cancer	0.0015	0.00417	CcSEcCtD
Papaverine—Discomfort—Tamoxifen—breast cancer	0.00149	0.00414	CcSEcCtD
Papaverine—Headache—Exemestane—breast cancer	0.00149	0.00414	CcSEcCtD
Papaverine—Verapamil—ABCC1—breast cancer	0.00145	0.0602	CrCbGaD
Papaverine—Diarrhoea—Anastrozole—breast cancer	0.00145	0.00402	CcSEcCtD
Papaverine—Diarrhoea—Letrozole—breast cancer	0.00145	0.00402	CcSEcCtD
Papaverine—Hepatitis—Mitoxantrone—breast cancer	0.00144	0.00399	CcSEcCtD
Papaverine—Discomfort—Goserelin—breast cancer	0.00142	0.00396	CcSEcCtD
Papaverine—Anorexia—Vinblastine—breast cancer	0.00142	0.00395	CcSEcCtD
Papaverine—Rash—Ixabepilone—breast cancer	0.00141	0.00393	CcSEcCtD
Papaverine—Dermatitis—Ixabepilone—breast cancer	0.00141	0.00393	CcSEcCtD
Papaverine—Nausea—Exemestane—breast cancer	0.00141	0.00393	CcSEcCtD
Papaverine—Decreased appetite—Chlorambucil—breast cancer	0.00141	0.00393	CcSEcCtD
Papaverine—Ill-defined disorder—Vinorelbine—breast cancer	0.00141	0.00391	CcSEcCtD
Papaverine—Headache—Ixabepilone—breast cancer	0.00141	0.00391	CcSEcCtD
Papaverine—Anorexia—Tamoxifen—breast cancer	0.00138	0.00383	CcSEcCtD
Papaverine—Diarrhoea—Idarubicin—breast cancer	0.00137	0.00382	CcSEcCtD
Papaverine—Diarrhoea—Raloxifene—breast cancer	0.00137	0.00382	CcSEcCtD
Papaverine—Malaise—Vinorelbine—breast cancer	0.00137	0.0038	CcSEcCtD
Papaverine—Vertigo—Vinorelbine—breast cancer	0.00136	0.00379	CcSEcCtD
Papaverine—Anorexia—Melphalan—breast cancer	0.00135	0.00375	CcSEcCtD
Papaverine—Feeling abnormal—Chlorambucil—breast cancer	0.00134	0.00372	CcSEcCtD
Papaverine—Nausea—Ixabepilone—breast cancer	0.00133	0.00371	CcSEcCtD
Papaverine—Flushing—Irinotecan—breast cancer	0.00133	0.00371	CcSEcCtD
Papaverine—Rash—Letrozole—breast cancer	0.00133	0.0037	CcSEcCtD
Papaverine—Rash—Anastrozole—breast cancer	0.00133	0.0037	CcSEcCtD
Papaverine—Dermatitis—Anastrozole—breast cancer	0.00133	0.0037	CcSEcCtD
Papaverine—Dermatitis—Letrozole—breast cancer	0.00133	0.0037	CcSEcCtD
Papaverine—Headache—Letrozole—breast cancer	0.00132	0.00368	CcSEcCtD
Papaverine—Headache—Anastrozole—breast cancer	0.00132	0.00368	CcSEcCtD
Papaverine—Anorexia—Goserelin—breast cancer	0.00132	0.00366	CcSEcCtD
Papaverine—Decreased appetite—Vinblastine—breast cancer	0.00129	0.0036	CcSEcCtD
Papaverine—Discomfort—Vinorelbine—breast cancer	0.00127	0.00354	CcSEcCtD
Papaverine—Constipation—Vinblastine—breast cancer	0.00127	0.00354	CcSEcCtD
Papaverine—Rash—Raloxifene—breast cancer	0.00126	0.00352	CcSEcCtD
Papaverine—Rash—Idarubicin—breast cancer	0.00126	0.00352	CcSEcCtD
Papaverine—Dermatitis—Raloxifene—breast cancer	0.00126	0.00351	CcSEcCtD
Papaverine—Dermatitis—Idarubicin—breast cancer	0.00126	0.00351	CcSEcCtD
Papaverine—Decreased appetite—Tamoxifen—breast cancer	0.00126	0.0035	CcSEcCtD
Papaverine—Headache—Idarubicin—breast cancer	0.00126	0.00349	CcSEcCtD
Papaverine—Headache—Raloxifene—breast cancer	0.00126	0.00349	CcSEcCtD
Papaverine—Nausea—Anastrozole—breast cancer	0.00126	0.00349	CcSEcCtD
Papaverine—Nausea—Letrozole—breast cancer	0.00126	0.00349	CcSEcCtD
Papaverine—Constipation—Tamoxifen—breast cancer	0.00124	0.00344	CcSEcCtD
Papaverine—Decreased appetite—Melphalan—breast cancer	0.00123	0.00342	CcSEcCtD
Papaverine—Feeling abnormal—Vinblastine—breast cancer	0.00123	0.00341	CcSEcCtD
Papaverine—Decreased appetite—Goserelin—breast cancer	0.0012	0.00334	CcSEcCtD
Papaverine—Nausea—Raloxifene—breast cancer	0.00119	0.00331	CcSEcCtD
Papaverine—Nausea—Idarubicin—breast cancer	0.00119	0.00331	CcSEcCtD
Papaverine—Constipation—Goserelin—breast cancer	0.00118	0.00328	CcSEcCtD
Papaverine—Anorexia—Vinorelbine—breast cancer	0.00118	0.00328	CcSEcCtD
Papaverine—Ill-defined disorder—Mitoxantrone—breast cancer	0.00116	0.00322	CcSEcCtD
Papaverine—Ill-defined disorder—Irinotecan—breast cancer	0.00116	0.00322	CcSEcCtD
Papaverine—Abdominal discomfort—Capecitabine—breast cancer	0.00115	0.0032	CcSEcCtD
Papaverine—Feeling abnormal—Goserelin—breast cancer	0.00114	0.00316	CcSEcCtD
Papaverine—Ill-defined disorder—Gemcitabine—breast cancer	0.00113	0.00314	CcSEcCtD
Papaverine—Malaise—Mitoxantrone—breast cancer	0.00113	0.00313	CcSEcCtD
Papaverine—Malaise—Irinotecan—breast cancer	0.00113	0.00313	CcSEcCtD
Papaverine—Anorexia—Thiotepa—breast cancer	0.00113	0.00313	CcSEcCtD
Papaverine—Vertigo—Irinotecan—breast cancer	0.00112	0.00312	CcSEcCtD
Papaverine—Diarrhoea—Chlorambucil—breast cancer	0.00111	0.00309	CcSEcCtD
Papaverine—Malaise—Gemcitabine—breast cancer	0.0011	0.00305	CcSEcCtD
Papaverine—Flushing—Paclitaxel—breast cancer	0.00109	0.00302	CcSEcCtD
Papaverine—Decreased appetite—Vinorelbine—breast cancer	0.00108	0.00299	CcSEcCtD
Papaverine—Constipation—Vinorelbine—breast cancer	0.00106	0.00294	CcSEcCtD
Papaverine—Discomfort—Irinotecan—breast cancer	0.00105	0.00292	CcSEcCtD
Papaverine—Discomfort—Mitoxantrone—breast cancer	0.00105	0.00292	CcSEcCtD
Papaverine—Decreased appetite—Thiotepa—breast cancer	0.00103	0.00286	CcSEcCtD
Papaverine—Discomfort—Gemcitabine—breast cancer	0.00102	0.00285	CcSEcCtD
Papaverine—Feeling abnormal—Vinorelbine—breast cancer	0.00102	0.00283	CcSEcCtD
Papaverine—Diarrhoea—Vinblastine—breast cancer	0.00102	0.00283	CcSEcCtD
Papaverine—Constipation—Thiotepa—breast cancer	0.00101	0.00281	CcSEcCtD
Papaverine—Discomfort—Fluorouracil—breast cancer	0.00101	0.0028	CcSEcCtD
Papaverine—Tofisopam—CYP3A4—breast cancer	0.000996	0.0413	CrCbGaD
Papaverine—Hepatitis—Docetaxel—breast cancer	0.000993	0.00276	CcSEcCtD
Papaverine—Diarrhoea—Tamoxifen—breast cancer	0.000989	0.00275	CcSEcCtD
Papaverine—Feeling abnormal—Thiotepa—breast cancer	0.000974	0.00271	CcSEcCtD
Papaverine—Anorexia—Irinotecan—breast cancer	0.000973	0.0027	CcSEcCtD
Papaverine—Anorexia—Mitoxantrone—breast cancer	0.000973	0.0027	CcSEcCtD
Papaverine—Diarrhoea—Melphalan—breast cancer	0.000969	0.00269	CcSEcCtD
Papaverine—Nausea—Chlorambucil—breast cancer	0.000965	0.00268	CcSEcCtD
Papaverine—Hepatitis—Capecitabine—breast cancer	0.000961	0.00267	CcSEcCtD
Papaverine—Anorexia—Gemcitabine—breast cancer	0.000947	0.00263	CcSEcCtD
Papaverine—Ill-defined disorder—Paclitaxel—breast cancer	0.000946	0.00263	CcSEcCtD
Papaverine—Diarrhoea—Goserelin—breast cancer	0.000945	0.00263	CcSEcCtD
Papaverine—Headache—Vinblastine—breast cancer	0.000933	0.00259	CcSEcCtD
Papaverine—Anorexia—Fluorouracil—breast cancer	0.000931	0.00259	CcSEcCtD
Papaverine—Trimethoprim—CYP3A4—breast cancer	0.000926	0.0384	CrCbGaD
Papaverine—Flushing—Docetaxel—breast cancer	0.000921	0.00256	CcSEcCtD
Papaverine—Malaise—Paclitaxel—breast cancer	0.000919	0.00256	CcSEcCtD
Papaverine—Vertigo—Paclitaxel—breast cancer	0.000916	0.00255	CcSEcCtD
Papaverine—Rash—Tamoxifen—breast cancer	0.000912	0.00254	CcSEcCtD
Papaverine—Dermatitis—Tamoxifen—breast cancer	0.000911	0.00253	CcSEcCtD
Papaverine—Headache—Tamoxifen—breast cancer	0.000906	0.00252	CcSEcCtD
Papaverine—Rash—Melphalan—breast cancer	0.000893	0.00248	CcSEcCtD
Papaverine—Flushing—Capecitabine—breast cancer	0.000892	0.00248	CcSEcCtD
Papaverine—Dermatitis—Melphalan—breast cancer	0.000892	0.00248	CcSEcCtD
Papaverine—Decreased appetite—Mitoxantrone—breast cancer	0.000887	0.00247	CcSEcCtD
Papaverine—Decreased appetite—Irinotecan—breast cancer	0.000887	0.00247	CcSEcCtD
Papaverine—Nausea—Vinblastine—breast cancer	0.000884	0.00246	CcSEcCtD
Papaverine—Constipation—Irinotecan—breast cancer	0.000872	0.00243	CcSEcCtD
Papaverine—Constipation—Mitoxantrone—breast cancer	0.000872	0.00243	CcSEcCtD
Papaverine—Rash—Goserelin—breast cancer	0.000871	0.00242	CcSEcCtD
Papaverine—Dermatitis—Goserelin—breast cancer	0.00087	0.00242	CcSEcCtD
Papaverine—Headache—Goserelin—breast cancer	0.000865	0.00241	CcSEcCtD
Papaverine—Decreased appetite—Gemcitabine—breast cancer	0.000864	0.0024	CcSEcCtD
Papaverine—Nausea—Tamoxifen—breast cancer	0.000859	0.00239	CcSEcCtD
Papaverine—Discomfort—Paclitaxel—breast cancer	0.000858	0.00238	CcSEcCtD
Papaverine—Abdominal discomfort—Methotrexate—breast cancer	0.000857	0.00238	CcSEcCtD
Papaverine—Constipation—Gemcitabine—breast cancer	0.00085	0.00236	CcSEcCtD
Papaverine—Decreased appetite—Fluorouracil—breast cancer	0.000849	0.00236	CcSEcCtD
Papaverine—Diarrhoea—Vinorelbine—breast cancer	0.000846	0.00235	CcSEcCtD
Papaverine—Nausea—Melphalan—breast cancer	0.000841	0.00234	CcSEcCtD
Papaverine—Feeling abnormal—Mitoxantrone—breast cancer	0.000841	0.00234	CcSEcCtD
Papaverine—Feeling abnormal—Irinotecan—breast cancer	0.000841	0.00234	CcSEcCtD
Papaverine—Nausea—Goserelin—breast cancer	0.00082	0.00228	CcSEcCtD
Papaverine—Feeling abnormal—Gemcitabine—breast cancer	0.000819	0.00228	CcSEcCtD
Papaverine—Diarrhoea—Thiotepa—breast cancer	0.000808	0.00225	CcSEcCtD
Papaverine—Feeling abnormal—Fluorouracil—breast cancer	0.000805	0.00224	CcSEcCtD
Papaverine—Anorexia—Paclitaxel—breast cancer	0.000793	0.00221	CcSEcCtD
Papaverine—Rash—Vinorelbine—breast cancer	0.00078	0.00217	CcSEcCtD
Papaverine—Dermatitis—Vinorelbine—breast cancer	0.000779	0.00217	CcSEcCtD
Papaverine—Ill-defined disorder—Capecitabine—breast cancer	0.000776	0.00216	CcSEcCtD
Papaverine—Headache—Vinorelbine—breast cancer	0.000775	0.00215	CcSEcCtD
Papaverine—Trimethoprim—ABCB1—breast cancer	0.000771	0.032	CrCbGaD
Papaverine—Verapamil—ABCG2—breast cancer	0.000766	0.0318	CrCbGaD
Papaverine—Malaise—Capecitabine—breast cancer	0.000754	0.0021	CcSEcCtD
Papaverine—Vertigo—Capecitabine—breast cancer	0.000752	0.00209	CcSEcCtD
Papaverine—Rash—Thiotepa—breast cancer	0.000745	0.00207	CcSEcCtD
Papaverine—Dermatitis—Thiotepa—breast cancer	0.000744	0.00207	CcSEcCtD
Papaverine—Headache—Thiotepa—breast cancer	0.00074	0.00206	CcSEcCtD
Papaverine—Nausea—Vinorelbine—breast cancer	0.000735	0.00204	CcSEcCtD
Papaverine—Decreased appetite—Paclitaxel—breast cancer	0.000723	0.00201	CcSEcCtD
Papaverine—Hepatitis—Methotrexate—breast cancer	0.000715	0.00199	CcSEcCtD
Papaverine—Constipation—Paclitaxel—breast cancer	0.000712	0.00198	CcSEcCtD
Papaverine—Discomfort—Capecitabine—breast cancer	0.000704	0.00196	CcSEcCtD
Papaverine—Nausea—Thiotepa—breast cancer	0.000702	0.00195	CcSEcCtD
Papaverine—Diarrhoea—Mitoxantrone—breast cancer	0.000698	0.00194	CcSEcCtD
Papaverine—Diarrhoea—Irinotecan—breast cancer	0.000698	0.00194	CcSEcCtD
Papaverine—Feeling abnormal—Paclitaxel—breast cancer	0.000686	0.00191	CcSEcCtD
Papaverine—Diarrhoea—Gemcitabine—breast cancer	0.00068	0.00189	CcSEcCtD
Papaverine—Anorexia—Docetaxel—breast cancer	0.000672	0.00187	CcSEcCtD
Papaverine—Hepatitis—Epirubicin—breast cancer	0.00067	0.00186	CcSEcCtD
Papaverine—Diarrhoea—Fluorouracil—breast cancer	0.000669	0.00186	CcSEcCtD
Papaverine—Anorexia—Capecitabine—breast cancer	0.000651	0.00181	CcSEcCtD
Papaverine—Rash—Irinotecan—breast cancer	0.000643	0.00179	CcSEcCtD
Papaverine—Rash—Mitoxantrone—breast cancer	0.000643	0.00179	CcSEcCtD
Papaverine—Dermatitis—Irinotecan—breast cancer	0.000643	0.00179	CcSEcCtD
Papaverine—Dermatitis—Mitoxantrone—breast cancer	0.000643	0.00179	CcSEcCtD
Papaverine—Headache—Irinotecan—breast cancer	0.000639	0.00178	CcSEcCtD
Papaverine—Headache—Mitoxantrone—breast cancer	0.000639	0.00178	CcSEcCtD
Papaverine—Rash—Gemcitabine—breast cancer	0.000627	0.00174	CcSEcCtD
Papaverine—Dermatitis—Gemcitabine—breast cancer	0.000626	0.00174	CcSEcCtD
Papaverine—Headache—Gemcitabine—breast cancer	0.000623	0.00173	CcSEcCtD
Papaverine—Flushing—Epirubicin—breast cancer	0.000621	0.00173	CcSEcCtD
Papaverine—Hepatitis—Doxorubicin—breast cancer	0.00062	0.00172	CcSEcCtD
Papaverine—Rash—Fluorouracil—breast cancer	0.000616	0.00171	CcSEcCtD
Papaverine—Dermatitis—Fluorouracil—breast cancer	0.000616	0.00171	CcSEcCtD
Papaverine—Decreased appetite—Docetaxel—breast cancer	0.000613	0.0017	CcSEcCtD
Papaverine—Headache—Fluorouracil—breast cancer	0.000612	0.0017	CcSEcCtD
Papaverine—Nausea—Mitoxantrone—breast cancer	0.000606	0.00168	CcSEcCtD
Papaverine—Nausea—Irinotecan—breast cancer	0.000606	0.00168	CcSEcCtD
Papaverine—Constipation—Docetaxel—breast cancer	0.000603	0.00168	CcSEcCtD
Papaverine—Decreased appetite—Capecitabine—breast cancer	0.000594	0.00165	CcSEcCtD
Papaverine—Nausea—Gemcitabine—breast cancer	0.00059	0.00164	CcSEcCtD
Papaverine—Constipation—Capecitabine—breast cancer	0.000584	0.00162	CcSEcCtD
Papaverine—Feeling abnormal—Docetaxel—breast cancer	0.000581	0.00162	CcSEcCtD
Papaverine—Nausea—Fluorouracil—breast cancer	0.00058	0.00161	CcSEcCtD
Papaverine—Ill-defined disorder—Methotrexate—breast cancer	0.000578	0.00161	CcSEcCtD
Papaverine—Flushing—Doxorubicin—breast cancer	0.000575	0.0016	CcSEcCtD
Papaverine—Diarrhoea—Paclitaxel—breast cancer	0.000569	0.00158	CcSEcCtD
Papaverine—Feeling abnormal—Capecitabine—breast cancer	0.000563	0.00156	CcSEcCtD
Papaverine—Malaise—Methotrexate—breast cancer	0.000562	0.00156	CcSEcCtD
Papaverine—Vertigo—Methotrexate—breast cancer	0.00056	0.00156	CcSEcCtD
Papaverine—Ill-defined disorder—Epirubicin—breast cancer	0.000541	0.0015	CcSEcCtD
Papaverine—Malaise—Epirubicin—breast cancer	0.000526	0.00146	CcSEcCtD
Papaverine—Rash—Paclitaxel—breast cancer	0.000525	0.00146	CcSEcCtD
Papaverine—Dermatitis—Paclitaxel—breast cancer	0.000524	0.00146	CcSEcCtD
Papaverine—Discomfort—Methotrexate—breast cancer	0.000524	0.00146	CcSEcCtD
Papaverine—Vertigo—Epirubicin—breast cancer	0.000524	0.00146	CcSEcCtD
Papaverine—Headache—Paclitaxel—breast cancer	0.000521	0.00145	CcSEcCtD
Papaverine—Ill-defined disorder—Doxorubicin—breast cancer	0.0005	0.00139	CcSEcCtD
Papaverine—Nausea—Paclitaxel—breast cancer	0.000494	0.00137	CcSEcCtD
Papaverine—Discomfort—Epirubicin—breast cancer	0.00049	0.00136	CcSEcCtD
Papaverine—Malaise—Doxorubicin—breast cancer	0.000486	0.00135	CcSEcCtD
Papaverine—Vertigo—Doxorubicin—breast cancer	0.000485	0.00135	CcSEcCtD
Papaverine—Anorexia—Methotrexate—breast cancer	0.000485	0.00135	CcSEcCtD
Papaverine—Diarrhoea—Docetaxel—breast cancer	0.000483	0.00134	CcSEcCtD
Papaverine—Diarrhoea—Capecitabine—breast cancer	0.000467	0.0013	CcSEcCtD
Papaverine—Discomfort—Doxorubicin—breast cancer	0.000454	0.00126	CcSEcCtD
Papaverine—Anorexia—Epirubicin—breast cancer	0.000453	0.00126	CcSEcCtD
Papaverine—Verapamil—CYP2D6—breast cancer	0.000446	0.0185	CrCbGaD
Papaverine—Rash—Docetaxel—breast cancer	0.000445	0.00124	CcSEcCtD
Papaverine—Dermatitis—Docetaxel—breast cancer	0.000444	0.00124	CcSEcCtD
Papaverine—Decreased appetite—Methotrexate—breast cancer	0.000442	0.00123	CcSEcCtD
Papaverine—Headache—Docetaxel—breast cancer	0.000442	0.00123	CcSEcCtD
Papaverine—Rash—Capecitabine—breast cancer	0.000431	0.0012	CcSEcCtD
Papaverine—Dermatitis—Capecitabine—breast cancer	0.00043	0.0012	CcSEcCtD
Papaverine—Headache—Capecitabine—breast cancer	0.000428	0.00119	CcSEcCtD
Papaverine—Anorexia—Doxorubicin—breast cancer	0.00042	0.00117	CcSEcCtD
Papaverine—Nausea—Docetaxel—breast cancer	0.000419	0.00116	CcSEcCtD
Papaverine—Feeling abnormal—Methotrexate—breast cancer	0.000419	0.00116	CcSEcCtD
Papaverine—Decreased appetite—Epirubicin—breast cancer	0.000414	0.00115	CcSEcCtD
Papaverine—Constipation—Epirubicin—breast cancer	0.000407	0.00113	CcSEcCtD
Papaverine—Nausea—Capecitabine—breast cancer	0.000406	0.00113	CcSEcCtD
Papaverine—Feeling abnormal—Epirubicin—breast cancer	0.000392	0.00109	CcSEcCtD
Papaverine—Verapamil—CYP3A4—breast cancer	0.000383	0.0159	CrCbGaD
Papaverine—Decreased appetite—Doxorubicin—breast cancer	0.000383	0.00106	CcSEcCtD
Papaverine—Constipation—Doxorubicin—breast cancer	0.000376	0.00105	CcSEcCtD
Papaverine—Feeling abnormal—Doxorubicin—breast cancer	0.000363	0.00101	CcSEcCtD
Papaverine—Diarrhoea—Methotrexate—breast cancer	0.000348	0.000967	CcSEcCtD
Papaverine—Diarrhoea—Epirubicin—breast cancer	0.000325	0.000905	CcSEcCtD
Papaverine—Rash—Methotrexate—breast cancer	0.000321	0.000891	CcSEcCtD
Papaverine—Dermatitis—Methotrexate—breast cancer	0.00032	0.00089	CcSEcCtD
Papaverine—Verapamil—ABCB1—breast cancer	0.000319	0.0132	CrCbGaD
Papaverine—Headache—Methotrexate—breast cancer	0.000318	0.000885	CcSEcCtD
Papaverine—Nausea—Methotrexate—breast cancer	0.000302	0.000839	CcSEcCtD
Papaverine—Diarrhoea—Doxorubicin—breast cancer	0.000301	0.000837	CcSEcCtD
Papaverine—Rash—Epirubicin—breast cancer	0.0003	0.000834	CcSEcCtD
Papaverine—Dermatitis—Epirubicin—breast cancer	0.0003	0.000833	CcSEcCtD
Papaverine—Headache—Epirubicin—breast cancer	0.000298	0.000829	CcSEcCtD
Papaverine—Nausea—Epirubicin—breast cancer	0.000283	0.000786	CcSEcCtD
Papaverine—Rash—Doxorubicin—breast cancer	0.000278	0.000772	CcSEcCtD
Papaverine—Dermatitis—Doxorubicin—breast cancer	0.000277	0.000771	CcSEcCtD
Papaverine—Headache—Doxorubicin—breast cancer	0.000276	0.000767	CcSEcCtD
Papaverine—Nausea—Doxorubicin—breast cancer	0.000261	0.000727	CcSEcCtD
Papaverine—PDE3A—Signaling Pathways—PLA2G4A—breast cancer	6.11e-05	0.000127	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—PIK3CA—breast cancer	6.08e-05	0.000126	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MDM2—breast cancer	6.06e-05	0.000126	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—TP53—breast cancer	6.05e-05	0.000125	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RAF1—breast cancer	6.04e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CSF2—breast cancer	6.04e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGF1—breast cancer	6.04e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—RAF1—breast cancer	6.03e-05	0.000125	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—RELA—breast cancer	6.01e-05	0.000125	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NRG1—breast cancer	6e-05	0.000124	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SMAD4—breast cancer	5.98e-05	0.000124	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—ERBB2—breast cancer	5.97e-05	0.000124	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—H2AFX—breast cancer	5.95e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—IL2—breast cancer	5.95e-05	0.000123	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1R—breast cancer	5.95e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL2—breast cancer	5.93e-05	0.000123	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—CXCL8—breast cancer	5.92e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—E2F1—breast cancer	5.91e-05	0.000123	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TERT—breast cancer	5.91e-05	0.000123	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CB—breast cancer	5.9e-05	0.000122	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MTOR—breast cancer	5.9e-05	0.000122	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CB—breast cancer	5.88e-05	0.000122	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HES1—breast cancer	5.84e-05	0.000121	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PLA2G4A—breast cancer	5.81e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NCOR1—breast cancer	5.81e-05	0.00012	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—HRAS—breast cancer	5.78e-05	0.00012	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CSF2—breast cancer	5.74e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGF1—breast cancer	5.74e-05	0.000119	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FGFR1—breast cancer	5.74e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—RAF1—breast cancer	5.73e-05	0.000119	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NRG1—breast cancer	5.7e-05	0.000118	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SPP1—breast cancer	5.68e-05	0.000118	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CXCL8—breast cancer	5.67e-05	0.000117	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—H2AFX—breast cancer	5.66e-05	0.000117	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—IL2—breast cancer	5.66e-05	0.000117	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—CXCL8—breast cancer	5.65e-05	0.000117	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HIF1A—breast cancer	5.65e-05	0.000117	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—HRAS—breast cancer	5.63e-05	0.000117	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—E2F1—breast cancer	5.62e-05	0.000117	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB3—breast cancer	5.62e-05	0.000116	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR2—breast cancer	5.61e-05	0.000116	CbGpPWpGaD
Papaverine—PDE3B—Hemostasis—AKT1—breast cancer	5.6e-05	0.000116	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CB—breast cancer	5.6e-05	0.000116	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1B—breast cancer	5.53e-05	0.000115	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—LEP—breast cancer	5.52e-05	0.000114	CbGpPWpGaD
Papaverine—PDE10A—GPCR downstream signaling—AKT1—breast cancer	5.47e-05	0.000113	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CAV1—breast cancer	5.47e-05	0.000113	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CASP3—breast cancer	5.42e-05	0.000112	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL2—breast cancer	5.42e-05	0.000112	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KDR—breast cancer	5.41e-05	0.000112	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL2—breast cancer	5.4e-05	0.000112	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SPP1—breast cancer	5.4e-05	0.000112	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—IL6—breast cancer	5.39e-05	0.000112	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TERT—breast cancer	5.38e-05	0.000112	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—CXCL8—breast cancer	5.38e-05	0.000111	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB3—breast cancer	5.34e-05	0.000111	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR2—breast cancer	5.33e-05	0.000111	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CCND1—breast cancer	5.28e-05	0.000109	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ESR1—breast cancer	5.27e-05	0.000109	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—JUN—breast cancer	5.27e-05	0.000109	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CTNNB1—breast cancer	5.23e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FGFR1—breast cancer	5.23e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—FN1—breast cancer	5.2e-05	0.000108	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HIF1A—breast cancer	5.15e-05	0.000107	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NFKBIA—breast cancer	5.14e-05	0.000107	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL2—breast cancer	5.14e-05	0.000107	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MMP9—breast cancer	5.12e-05	0.000106	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TERT—breast cancer	5.12e-05	0.000106	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—CDKN1A—breast cancer	5.11e-05	0.000106	CbGpPWpGaD
Papaverine—PDE3A—Hemostasis—AKT1—breast cancer	5.1e-05	0.000106	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PTEN—breast cancer	5.1e-05	0.000106	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOTCH1—breast cancer	5.09e-05	0.000106	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—LEP—breast cancer	5.03e-05	0.000104	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK8—breast cancer	4.98e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KIT—breast cancer	4.98e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—APC—breast cancer	4.98e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CG—breast cancer	4.98e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CAV1—breast cancer	4.98e-05	0.000103	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FGFR1—breast cancer	4.97e-05	0.000103	CbGpPWpGaD
Papaverine—PDE10A—Signaling by GPCR—AKT1—breast cancer	4.97e-05	0.000103	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KDR—breast cancer	4.92e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGF—breast cancer	4.92e-05	0.000102	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HIF1A—breast cancer	4.9e-05	0.000102	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ESR1—breast cancer	4.8e-05	9.95e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—LEP—breast cancer	4.78e-05	9.91e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—MAPK3—breast cancer	4.77e-05	9.89e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—FN1—breast cancer	4.74e-05	9.83e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CAV1—breast cancer	4.74e-05	9.82e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—SRC—breast cancer	4.73e-05	9.8e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KDR—breast cancer	4.68e-05	9.71e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NFKBIA—breast cancer	4.68e-05	9.71e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—BRAF—breast cancer	4.68e-05	9.71e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOTCH1—breast cancer	4.64e-05	9.62e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—VEGFA—breast cancer	4.6e-05	9.54e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ESR1—breast cancer	4.56e-05	9.46e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IGF1—breast cancer	4.56e-05	9.45e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—STAT3—breast cancer	4.56e-05	9.45e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT2—breast cancer	4.56e-05	9.45e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—EGFR—breast cancer	4.54e-05	9.41e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CG—breast cancer	4.54e-05	9.4e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KIT—breast cancer	4.54e-05	9.4e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—APC—breast cancer	4.54e-05	9.4e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—FN1—breast cancer	4.51e-05	9.35e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGF—breast cancer	4.48e-05	9.3e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NFKBIA—breast cancer	4.45e-05	9.24e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOTCH1—breast cancer	4.41e-05	9.15e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CD—breast cancer	4.38e-05	9.08e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MAPK3—breast cancer	4.35e-05	9.03e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—MAPK3—breast cancer	4.34e-05	9.01e-05	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—PIK3CA—breast cancer	4.34e-05	8.99e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SERPINE1—breast cancer	4.33e-05	8.98e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CG—breast cancer	4.31e-05	8.94e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—APC—breast cancer	4.31e-05	8.94e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KIT—breast cancer	4.31e-05	8.94e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—KRAS—breast cancer	4.29e-05	8.89e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGF—breast cancer	4.26e-05	8.84e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—BRAF—breast cancer	4.26e-05	8.84e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—MYC—breast cancer	4.23e-05	8.78e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TGFB1—breast cancer	4.22e-05	8.76e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IGF1—breast cancer	4.15e-05	8.61e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT2—breast cancer	4.15e-05	8.6e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—EGFR—breast cancer	4.14e-05	8.59e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—NOS3—breast cancer	4.13e-05	8.57e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—EGFR—breast cancer	4.13e-05	8.57e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—MAPK3—breast cancer	4.13e-05	8.57e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—BRAF—breast cancer	4.05e-05	8.41e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CD—breast cancer	3.99e-05	8.27e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IGF1—breast cancer	3.95e-05	8.19e-05	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—PIK3CA—breast cancer	3.95e-05	8.19e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT2—breast cancer	3.95e-05	8.18e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SERPINE1—breast cancer	3.94e-05	8.18e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—PIK3CA—breast cancer	3.94e-05	8.16e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—EGFR—breast cancer	3.93e-05	8.15e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MDM2—breast cancer	3.92e-05	8.13e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—KRAS—breast cancer	3.91e-05	8.11e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RAF1—breast cancer	3.91e-05	8.1e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—KRAS—breast cancer	3.9e-05	8.09e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—RELA—breast cancer	3.89e-05	8.07e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—ERBB2—breast cancer	3.87e-05	8.02e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CB—breast cancer	3.82e-05	7.91e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MTOR—breast cancer	3.82e-05	7.91e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CD—breast cancer	3.79e-05	7.86e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—NOS3—breast cancer	3.76e-05	7.81e-05	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—PIK3CA—breast cancer	3.76e-05	7.79e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SERPINE1—breast cancer	3.75e-05	7.78e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—KRAS—breast cancer	3.71e-05	7.7e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CXCL8—breast cancer	3.67e-05	7.6e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—HRAS—breast cancer	3.64e-05	7.55e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—PIK3CA—breast cancer	3.59e-05	7.45e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—PIK3CA—breast cancer	3.59e-05	7.44e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—NOS3—breast cancer	3.58e-05	7.43e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1B—breast cancer	3.58e-05	7.42e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MDM2—breast cancer	3.57e-05	7.41e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RAF1—breast cancer	3.56e-05	7.38e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—RELA—breast cancer	3.54e-05	7.35e-05	CbGpPWpGaD
Papaverine—PDE3B—GPCR downstream signaling—AKT1—breast cancer	3.54e-05	7.34e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—ERBB2—breast cancer	3.52e-05	7.3e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CASP3—breast cancer	3.51e-05	7.28e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL2—breast cancer	3.5e-05	7.27e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—IL6—breast cancer	3.49e-05	7.23e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—TP53—breast cancer	3.48e-05	7.21e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CB—breast cancer	3.48e-05	7.21e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MTOR—breast cancer	3.48e-05	7.21e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CCND1—breast cancer	3.42e-05	7.08e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—PIK3CA—breast cancer	3.41e-05	7.07e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—JUN—breast cancer	3.41e-05	7.07e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MDM2—breast cancer	3.4e-05	7.04e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RAF1—breast cancer	3.39e-05	7.02e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CTNNB1—breast cancer	3.38e-05	7.01e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—RELA—breast cancer	3.37e-05	6.99e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—ERBB2—breast cancer	3.35e-05	6.95e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CXCL8—breast cancer	3.34e-05	6.92e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—HRAS—breast cancer	3.33e-05	6.9e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—HRAS—breast cancer	3.32e-05	6.88e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MMP9—breast cancer	3.32e-05	6.88e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MTOR—breast cancer	3.31e-05	6.85e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CB—breast cancer	3.31e-05	6.85e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—CDKN1A—breast cancer	3.3e-05	6.85e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PTEN—breast cancer	3.3e-05	6.84e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1B—breast cancer	3.26e-05	6.76e-05	CbGpPWpGaD
Papaverine—PDE3A—GPCR downstream signaling—AKT1—breast cancer	3.23e-05	6.69e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK8—breast cancer	3.23e-05	6.69e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling by GPCR—AKT1—breast cancer	3.22e-05	6.67e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CASP3—breast cancer	3.2e-05	6.63e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL2—breast cancer	3.19e-05	6.62e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—IL6—breast cancer	3.18e-05	6.6e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CXCL8—breast cancer	3.18e-05	6.59e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—IL6—breast cancer	3.18e-05	6.58e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—HRAS—breast cancer	3.16e-05	6.54e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CCND1—breast cancer	3.11e-05	6.45e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—JUN—breast cancer	3.1e-05	6.44e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1B—breast cancer	3.1e-05	6.43e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CTNNB1—breast cancer	3.08e-05	6.39e-05	CbGpPWpGaD
Papaverine—PDE4B—GPCR downstream signaling—AKT1—breast cancer	3.07e-05	6.36e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—SRC—breast cancer	3.06e-05	6.34e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CASP3—breast cancer	3.04e-05	6.3e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL2—breast cancer	3.04e-05	6.29e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MMP9—breast cancer	3.02e-05	6.26e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—IL6—breast cancer	3.02e-05	6.26e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—CDKN1A—breast cancer	3.01e-05	6.24e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PTEN—breast cancer	3e-05	6.23e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—VEGFA—breast cancer	2.98e-05	6.17e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CCND1—breast cancer	2.96e-05	6.14e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—JUN—breast cancer	2.95e-05	6.12e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—STAT3—breast cancer	2.95e-05	6.11e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK8—breast cancer	2.94e-05	6.09e-05	CbGpPWpGaD
Papaverine—PDE10A—Signaling Pathways—AKT1—breast cancer	2.94e-05	6.09e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CTNNB1—breast cancer	2.93e-05	6.08e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling by GPCR—AKT1—breast cancer	2.93e-05	6.07e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MMP9—breast cancer	2.87e-05	5.96e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—CDKN1A—breast cancer	2.86e-05	5.94e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PTEN—breast cancer	2.86e-05	5.92e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MAPK3—breast cancer	2.82e-05	5.84e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK8—breast cancer	2.79e-05	5.79e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling by GPCR—AKT1—breast cancer	2.79e-05	5.78e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—SRC—breast cancer	2.78e-05	5.77e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—MYC—breast cancer	2.74e-05	5.68e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TGFB1—breast cancer	2.73e-05	5.67e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—VEGFA—breast cancer	2.71e-05	5.62e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—STAT3—breast cancer	2.69e-05	5.57e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—EGFR—breast cancer	2.68e-05	5.56e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—SRC—breast cancer	2.65e-05	5.49e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—VEGFA—breast cancer	2.58e-05	5.35e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MAPK3—breast cancer	2.57e-05	5.32e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—STAT3—breast cancer	2.55e-05	5.3e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—KRAS—breast cancer	2.53e-05	5.25e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—MYC—breast cancer	2.5e-05	5.17e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TGFB1—breast cancer	2.49e-05	5.16e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—EGFR—breast cancer	2.44e-05	5.06e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MAPK3—breast cancer	2.44e-05	5.06e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—MYC—breast cancer	2.37e-05	4.92e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TGFB1—breast cancer	2.37e-05	4.91e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—PIK3CA—breast cancer	2.33e-05	4.82e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—EGFR—breast cancer	2.32e-05	4.81e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—KRAS—breast cancer	2.31e-05	4.78e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—TP53—breast cancer	2.25e-05	4.67e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—KRAS—breast cancer	2.19e-05	4.55e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—HRAS—breast cancer	2.15e-05	4.46e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—PIK3CA—breast cancer	2.12e-05	4.39e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—IL6—breast cancer	2.06e-05	4.27e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—TP53—breast cancer	2.05e-05	4.25e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—PIK3CA—breast cancer	2.01e-05	4.18e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—HRAS—breast cancer	1.96e-05	4.06e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—TP53—breast cancer	1.95e-05	4.04e-05	CbGpPWpGaD
Papaverine—PDE3B—Signaling Pathways—AKT1—breast cancer	1.9e-05	3.94e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—IL6—breast cancer	1.88e-05	3.89e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—HRAS—breast cancer	1.86e-05	3.87e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—IL6—breast cancer	1.78e-05	3.7e-05	CbGpPWpGaD
Papaverine—PDE3A—Signaling Pathways—AKT1—breast cancer	1.73e-05	3.59e-05	CbGpPWpGaD
Papaverine—PDE4B—Signaling Pathways—AKT1—breast cancer	1.65e-05	3.41e-05	CbGpPWpGaD
